Good News from Ruisheng-Ethyl Acetate CDE Platform Status Leaps to A, Quality Strength Recognized by Authority Again
in the field of medicine, every breakthrough means to contribute to the cause of health. Recently, Shandong Ruisheng Pharmaceutical Accessories Co., Ltd. received an exciting news: the state of the company's ethyl acetate products on the (CDE) platform of the Drug Evaluation Center of the State Drug Administration has successfully changed from "I" to "A" state. This change is like a green light for the product, which is of great significance.
shandong ruisheng pharmaceutical excipients limited company since its inception in 2012, has always focused on research and development and production of pharmaceutical excipients. The company is rooted in Dong'e County, the hometown of Ejiao. With a total investment of 0.13 billion yuan, an area of 50 acres and a construction area of 8000 square meters, it has built a solid production capacity with an annual output of 10000 tons of new pharmaceutical excipients. In the production process, we strictly follow the GMP requirements for the production of pharmaceutical excipients, relying on advanced equipment such as stainless steel reactors and automatic filling machines, and are committed to providing high-quality excipients for the pharmaceutical industry.
Ethyl acetate, as a key product of the company, plays an important role in pharmaceutical preparations. It presents as a colorless and transparent liquid with fruit aroma. It can not only be used as a solvent to help the dissolution and dispersion of the active ingredients of the drug, but also act as a fragrance to improve the smell and taste of the drug, thereby enhancing the patient's medication experience, from oral preparations To external preparations, ethyl acetate plays an indispensable role.
This upgrade in the status of the CDE platform is a high recognition of the R & D strength, product quality and compliance operations of Resheng Pharmaceuticals. All along, Ruisheng medicine auxiliary uphold the "quality first, service first" concept, continue to enrich the product range. From the initial light liquid paraffin oil, polysorbate 80 and other 24 varieties, to today's expanding product matrix, the company has always kept up with market demand and industry trends. In the future, Ruisheng Pharmaceutical will take this opportunity to continue to increase investment in research and development, optimize production processes, inject continuous vitality into the pharmaceutical and health industry, and contribute more to the protection of public health.
